Log in to save to my catalogue

A truncated fragment of Ov -ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain mainta...

A truncated fragment of Ov -ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain mainta...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7115538

A truncated fragment of Ov -ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length protein

About this item

Full title

A truncated fragment of Ov -ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length protein

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2015-04, Vol.33 (16), p.1974-1980

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

Highlights • Ov -ASP-1, an onchocerca volvulus protein, has good adjuvanticity for protein antigens. • A truncated Ov -ASP-1 (ASPPR) maintains adjuvanticity as the full-length of Ov -ASP-1. • ASPPR augments humoral and cellular immune responses elicited by protein antigens. • ASPPR has potential to be further developed as a novel adjuvant for human...

Alternative Titles

Full title

A truncated fragment of Ov -ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length protein

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7115538

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7115538

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2015.02.053

How to access this item